Newsfiscal.ai
Werewolf Therapeutics Selected for Oral Presentation and Poster Sessions at SITC 2026 Annual Meeting
· Published
Article summary
Werewolf Therapeutics, Inc. announced its selection to present clinical and scientific data at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…